Figure 1.
Within and between-group statistical analysis of SBP, DBP, HR, and PSQI before and after intervention
| Variable | TEAS group (n = 20) | P within time | Control group (n = 20) | P between groups | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before intervention | After intervention | MD (95% CI) | % of change | Before intervention | After intervention | MD (95% CI) | % of change | |||
| SBP (mm Hg) | 151.20 ± 4.48 | 134.85 ± 3.82 | −16.35 (−18.79, −13.91) | 10.81%↓ | < 0.001* | 151.20 ± 4.18 | 146.50 ± 4.52 | −4.70 (−5.86, −3.54) | 3.11%↓ | < 0.001* |
| DBP (mm Hg) | 93.15 ± 2.08 | 85.50 ± 2.3 | −7.65 (−9.22, −6.0) | 8.21%↓ | < 0.001* | 92.30 ± 1.92 | 89.05 ± 1.64 | −3.25 (−4.01, −2.49) | 3.52%↓ | < 0.001* |
| HR (Beats/min) | 83.95 ± 8.59 | 71.80 ± 5.89 | −12.15 (−15.82, −8.48) | 14.47%↓ | < 0.001* | 87.00 ± 6.92 | 82.90 ± 7.72 | −4.10 (−6.29, −1.90) | 5.41%↓ | < 0.001* |
| PSQI (Score) | 14.00 ± 2.22 | 9.15 ± 1.69 | −4.85 (−5.99, −3.71) | 34.64%↓ | < 0.001* | 14.55 ± 2.24 | 14.15 ± 2.11 | −0.40 (−0.64, −0.16) | 2.75%↓ | < 0.001* |
Within and between-group statistical analysis of NO, SF12 PCS, and SF12 MCS before and after intervention
| Variable | TEAS group (n = 20) | P within time | Control group (n = 20) | P between groups | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before intervention | After intervention | MD (95% CI) | % of change | Before intervention | After intervention | MD (95% CI) | % of change | |||
| Nitric oxide (μmole/L) | 6.56 ± 1.59 | 9.89 ± 1.51 | 3.33 (2.39, 4.28) | 50.76%↑ | < 0.001* | 6.52 ± 1.53 | 6.82 ± 1.55 | 0.30 (−0.13, 0.74) | 4.60%↑ | < 0.001* |
| Sf12 PCS | 35.54 ± 4.63 | 41.41 ± 4.46 | 5.87 (4.66, 7.08) | 16.52%↑ | < 0.001* | 34.23 ± 5.01 | 34.78 ± 4.02 | 0.55 (−0.52, 1.61) | 1.61%↑ | < 0.001* |
| Sf12 MCS | 36.43 ± 5.29 | 45.76 ± 2.47 | 9.33 (6.34, 12.32) | 25.61%↑ | < 0.001* | 36.29 ± 5.19 | 37.44 ± 4.53 | 1.15 (−2.29, 4.57) | 3.17%↑ | < 0.001* |
Demographic characteristics of patients of the two groups
| Variables | Total (n = 40) | TEAS group (n = 20) | Control group (n = 20) | Test of significance | P-value |
|---|---|---|---|---|---|
| Age (Years) | 55.20 ± 3.23 | 55.25 ± 3.29 | 55.15 ± 3.25 | T = 0.097 | 0.923 |
| 51.00–60.00 | 51.00–60.00 | 51.00–60.00 | |||
| Sex, N (%) | X2 = 2.133 | 0.144 | |||
| Male | 30 (75.0%) | 13 (65.0%) | 17 (85.0%) | ||
| Female | 10 (25.0%) | 7 (35.0%) | 3 (15.0%) | ||
| Weight (kg) | 81.80 ± 8.94 | 84.00 ± 8.53 | 79.60 ± 8.99 | T = 1.587 | 0.121 |
| 66.00–110.00 | 70.00–110.00 | 66.00–98.00 | |||
| Height (cm) | 166.10 ± 5.67 | 166.90 ± 6.09 | 165.30 ±5.24 | T = 0.890 | 0.379 |
| 155.00–180.00 | 155.00–180.00 | 159.00–177.00 | |||
| BMI (kg /m2) | 29.56 ± 2.30 | 30.17 ± 2.52 | 28.96 ± 1.94 | T = 1.705 | 0.096 |
| 26.40–34.5 | 27.00–34.5 | 26.40–33.00 | |||